June 25, 2009 – Six-month follow-up results were released this week for a patient treated with adult stem cells in a clinical study of idiopathic dilated cardiomyopathy, which showed major improvement in cardiac function.
The clinical study is a collaborative effort among physicians at Regenocyte Therapeutic, the American Institute for Regenerative Medicine, and researchers and scientists from TheraVitae.
Leonard Narracci, 71, from Venice, Fla., underwent the adult stem cell therapy in October 2008. Since being diagnosed with idiopathic dilated cardiomyopathy and congestive heart failure, Narracci's ejection fraction was severely reduced at 18 percent (with normal being more than 55 percent). Within three months of the treatment, his ejection fraction improved to 40 percent and is now at 51 percent.
“It goes against traditional theory that we should try to fix damaged heart muscle, but we are generating new heart tissue with impressive results that improve cardiac function and quality of life,” said Leonel Fernandez Liriano, professor of medicine at Pontifical Catholic University School of Medicine (PCUSM) and head of the cardiology team that treated the patient with adult stem cells.
Regenocyte Therapeutic has treated several similar patients who are demonstrating correlative improvements. “We have had success in the ischemic heart disease patients since 2006, and it is encouraging to see that the technology can now be applied to other diseases,” Dr. Grekos said.
For more information: regenocyte.com